Literature DB >> 8030854

Aging, stress, and cognitive function.

A Levy1, S Dachir, I Arbel, T Kadar.   

Abstract

Stress was implied as involved in "enhanced aging," and prolonged administration of corticosterone was claimed to lead to central neuronal lesions. This study describes an animal model that simulates the steroid elevation associated with stress by a continuous slow-release administration of corticosterone, in young (3 months old) and middle-aged (12 months old) Fischer 344 rats. Plasma concentrations of corticosterone were stable throughout the day, with no diurnal variation, within the range associated with mild stress. Corticosterone prolonged treatment resulted in morphological changes mainly in the CA1, CA4, and dentate gyrus areas of the hippocampus. Middle-aged rats showed higher vulnerability to the long-term COR treatment than young ones, even when COR treatment was prolonged in young rats from 63 to 90 days. Middle-aged rats were screened before the corticosterone treatment, using the Morris water maze, and divided between cognitively "impaired" and "nonimpaired" subpopulations. Severe cognitive damage during acquisition of the eight-arm radial maze was shown, after the continuous hormonal treatment, in rats initially defined as "nonimpaired" in the Morris water maze. This animal model might be useful for testing the protective effects of drugs against brain changes and cognitive damage, during either pathological or normal aging.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030854     DOI: 10.1111/j.1749-6632.1994.tb12075.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Concentration dependent actions of glucocorticoids on neuronal viability and survival.

Authors:  István M Abrahám; Peter Meerlo; Paul G M Luiten
Journal:  Dose Response       Date:  2006-06-20       Impact factor: 2.658

2.  Objective and Subjective Cognitive Problems among Caregivers and Matched Non-caregivers.

Authors:  Peter P Vitaliano; Ozge Ustundag; Soo Borson
Journal:  Gerontologist       Date:  2017-08-01

Review 3.  Glucocorticoids and the ageing hippocampus.

Authors:  C Hibberd; J L Yau; J R Seckl
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

4.  Aversive stimulus attenuates impairment of acquisition in a delayed match to position T-maze task caused by a selective lesion of septo-hippocampal cholinergic projections.

Authors:  Nicholas F Fitz; Robert B Gibbs; David A Johnson
Journal:  Brain Res Bull       Date:  2006-04-18       Impact factor: 4.077

5.  Depressed mood mediates decline in cognitive processing speed in caregivers.

Authors:  Peter P Vitaliano; Jianping Zhang; Heather M Young; Lisa W Caswell; James M Scanlan; Diana Echeverria
Journal:  Gerontologist       Date:  2009-03-18

Review 6.  Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression.

Authors:  Rita Businaro; David Vauzour; Jerome Sarris; Gerald Münch; Erika Gyengesi; Laura Brogelli; Pedro Zuzarte
Journal:  Front Nutr       Date:  2021-05-14

7.  Interaction of stress, lead burden, and age on cognition in older men: the VA Normative Aging Study.

Authors:  Junenette L Peters; Marc G Weisskopf; Avron Spiro; Joel Schwartz; David Sparrow; Huiling Nie; Howard Hu; Robert O Wright; Rosalind J Wright
Journal:  Environ Health Perspect       Date:  2009-11-06       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.